About Cassava Sciences Inc
Cassava Sciences is a US clinical-stage biopharmaceutical company with a focus on neuroscience. It was founded in 1998 with headquarters in Austin, Texas. The business develops medicines for patients with debilitating neurodegenerative conditions, such as Alzheimer’s, Huntington’s, and Parkinson’s disease. Cassava’s main products include Simufilam, an investigative oral drug that aims to stabilise critical proteins in the brain, and SavaDx, a blood-based diagnostic used to detect Alzheimer’s disease. It has previously worked drugs aimed to treat irritable bowel syndrome (IBS). Cassava Sciences stock is listed on the Nasdaq exchange in New York. Start spread betting or trading CFDs on our Cassava Sciences share price.
Constituent weightings
Component |
Weighting |
1 Day |
1 Month |
3 Month |
Related instruments
Why trade Cassava Sciences Inc with CMC Markets?
We've invested over £100m into our trading platform, creating pioneering technology that puts powerful software in your hands.
-
One-click trading
Set your default position size and enter with a single 'click'.
-
99.9% fill rate with 0.0029s execution*
Wherever possible we fill your trade and always at the price you see.
-
99.95%+ platform stability**
We consistently achieve core platform uptime, allowing you to focus on your trading.
-
Precise pricing
We crunch 225m prices every day, from up to 14 feeds from tier one liquidity providers.
Related news